Wed, August 4, 2021

Geoffrey Porges Maintained (TBPH) at Buy with Increased Target to $37 on, Aug 4th, 2021

Geoffrey Porges of SVB Leerink, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Increased Target from $36 to $37 on, Aug 4th, 2021.

Geoffrey has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Geoffrey's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Geoffrey


  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $27 on, Friday, July 16th, 2021
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $32 on, Wednesday, May 5th, 2021